Notably, AngII treatment did not worsen survival relative to PBS, which may be due to high levels of AT1R activation in vehicle conditions from higher levels of circulating AngII, as has been observed in patients with PAH (4). The gene discussed is AGTR1; the disease is pulmonary arterial hypertension.